Halaman 2 - Limfangioma Dokter Terbaik - TOP-43 dokter

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Osama Abdel Mohimen Mohamed is Head of the Hematology Unit at Shefaa Al Orman Oncology Hospitals. He is also a consultant in medical oncology and hematology at Shefa El Orman Hospital (NGO), Luxor (2019–present).

He diagnoses and treats acute and chronic leukemia, lymphoma, myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms. He also manages complications of solid tumors.

Background: He served at the National Cancer Institute, Cairo University, as a medical oncology resident, then demonstrator and assistant lecturer (2008–2022). Earlier, he was a house officer (2006–2007). He also held specialist roles at Al Salam International, Al Molalmen, and BAHEYA Oncology Center (NGO).

Memberships: ESMO (2008–present). American Society of Bone Marrow Transplantation (2009). ASH (2010).

Spesialis dalam onkologi radiasi di Universitas Marmara – terlatih khusus untuk kondisi limfatik yang kompleks.

• Lulus dari Fakultas Kedokteran Universitas Marmara
• Menyelesaikan pelatihan spesialisasi dalam onkologi radiasi
• Bekerja di Rumah Sakit Emsey

Dr. Topcu menghadirkan keahlian onkologi khusus untuk kasus limfangioma dengan pelatihan di pusat kanker internasional terkemuka.

• Residensi onkologi medis di Universitas Teknik Karadeniz
• Dilatih di MD Anderson Cancer Center dan Moffitt Cancer Center
• Anggota asosiasi profesional ESMO dan ASCO
• Berrpaktik di Biruni University Hospital

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Associate Professor Dr. Emrah Eraslan berspesialisasi dalam onkologi, dengan pengalaman luas dalam mengobati berbagai jenis kanker di Rumah Sakit Koru Ankara.

• Lulus dari Fakultas Kedokteran Universitas Ankara pada tahun 2005
• Menyelesaikan pelatihan onkologi medis di Rumah Sakit Pendidikan dan Penelitian Onkologi Dr. Abdurrahman Yurtaslan Ankara
• Menjadi associate professor pada tahun 2023 dengan berbagai publikasi
• Minat khusus meliputi kanker payudara, prostat, paru-paru, kolorektal, lambung, dan ovarium

Lebih dari 50.000 bedah kanker selama 19 tahun – Dr. Nagarkar berspesialisasi dalam onkologi bedah di HCG Manavata Cancer Centre, dengan fokus pada peningkatan kualitas hidup pasien.

• Menempuh pelatihan di Tata Memorial Hospital dan Royal College of Surgeons, Edinburgh
• Berspesialisasi dalam onkologi bedah payudara dan toraks
• Terlibat dalam lebih dari 200 uji klinis (fase 1-3)
• Profesor untuk Subspesialis Bedah Onkologi DNB dan Bedah Payudara

Dr. Shruti Kate spesialis dalam terapi kanker agresif dengan fokus utama pada pendekatan imunoterapi baru di HCG Manavata Cancer Centre.

• Pelatihan di Tata Memorial Hospital – salah satu pusat kanker terkemuka di Asia
• Spesialisasi dalam kanker paru-paru dan tumor pediatrik
• Presentasi penelitian tentang terapi kanker paru-paru secara internasional
• Anggota ASCO, ESMO, dan kelompok onkologi terkemuka lainnya
• Pengembangan protokol khusus untuk perawatan terapi metronomik

Menangani lebih dari 30.000 pemindaian PET dan 1.000 pasien kanker tiroid – Dr. Borde adalah spesialis kedokteran nuklir di HCG Manavata Cancer Centre.

• 12 tahun pengalaman dalam kedokteran nuklir
• Mahir dalam terapi radioiodine & Lu-177 RN
• Ahli dalam pemindaian PET-CT dan layanan kardiologi nuklir
• Penelitian yang dipublikasikan di berbagai jurnal medis

Dr. Sridhar P.S. spesialis dalam radioterapi dengan pelatihan ekstensif di bidang onkologi, yang berfokus pada pendekatan pengobatan yang tepat dan efektif.

• Lebih dari 20 tahun pengalaman dalam radioterapi
• Diplomate of National Board di bidang radioterapi
• Anggota Society for Neuro-Oncology
• Terasosiasi dengan Indian Association of Hyperthermia Oncology

Prof. Kayihan Engin memiliki lebih dari 30 tahun keahlian dalam onkologi radiasi, dengan pelatihan fellowship spesialis di Thomas Jefferson University.

• Mantan Ketua Onkologi Radiasi di Universitas Uludağ
• Fellowship pasca-doktoral dalam Termoradioterapi di AS
• Direktur Ilmu Onkologi di Rumah Sakit Medicana Bursa
• Beasiswa penelitian di National Cancer Institute, AS

Dengan pengalaman lebih dari 20 tahun, Assoc. Dr. Ugur Ekici mengkhususkan diri dalam bedah laparoskopi tingkat lanjut dan bedah kanker di Rumah Sakit Medicana Bahcelievler.

• Menjalani pelatihan di Klinik Bedah Umum Rumah Sakit Şişli Etfal
• Menerbitkan artikel di jurnal wasit internasional
• Mengkhususkan diri dalam bedah obesitas, metabolik, tiroid, dan paratiroid